Windlas Biotech debuts at Rs 439 per share over issue price
The initial public offering (IPO) of Windlas Biotech, one the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization industry in terms of revenue, started off the first day trade at Rs 439 per share…
